Literature DB >> 28495692

Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis.

Pierre-Antoine Juge1,2,3, Raphaël Borie2,4,5,3, Caroline Kannengiesser2,6,7,3, Steven Gazal2,8,9, Patrick Revy10,11, Lidwine Wemeau-Stervinou12,13, Marie-Pierre Debray2,14, Sébastien Ottaviani1,2, Sylvain Marchand-Adam15,16,17, Nadia Nathan18,19,20, Gabriel Thabut2,5,21, Christophe Richez22,23,24, Hilario Nunes25,26, Isabelle Callebaut20,27, Aurélien Justet2,4, Nicolas Leulliot11,28, Amélie Bonnefond13,29,30, David Salgado31,32, Pascal Richette2,33,34, Jean-Pierre Desvignes31,32, Huguette Lioté35, Philippe Froguel13,29,36, Yannick Allanore11,37,38, Olivier Sand13,29,30, Claire Dromer24,39, René-Marc Flipo13,40, Annick Clément18,19,20, Christophe Béroud31,32,41, Jean Sibilia42,43,44, Baptiste Coustet1,2, Vincent Cottin45,46, Marie-Christophe Boissier26,47,48, Benoit Wallaert12,13, Thierry Schaeverbeke22,23,24, Florence Dastot le Moal18,20,49, Aline Frazier2,33, Christelle Ménard18,19,20, Martin Soubrier50, Nathalie Saidenberg26,48, Dominique Valeyre25,26, Serge Amselem18,19,49, Catherine Boileau2,6,51, Bruno Crestani2,4,5, Philippe Dieudé52,2,7.   

Abstract

Despite its high prevalence and mortality, little is known about the pathogenesis of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Given that familial pulmonary fibrosis (FPF) and RA-ILD frequently share the usual pattern of interstitial pneumonia and common environmental risk factors, we hypothesised that the two diseases might share additional risk factors, including FPF-linked genes. Our aim was to identify coding mutations of FPF-risk genes associated with RA-ILD.We used whole exome sequencing (WES), followed by restricted analysis of a discrete number of FPF-linked genes and performed a burden test to assess the excess number of mutations in RA-ILD patients compared to controls.Among the 101 RA-ILD patients included, 12 (11.9%) had 13 WES-identified heterozygous mutations in the TERT, RTEL1, PARN or SFTPC coding regions. The burden test, based on 81 RA-ILD patients and 1010 controls of European ancestry, revealed an excess of TERT, RTEL1, PARN or SFTPC mutations in RA-ILD patients (OR 3.17, 95% CI 1.53-6.12; p=9.45×10-4). Telomeres were shorter in RA-ILD patients with a TERT, RTEL1 or PARN mutation than in controls (p=2.87×10-2).Our results support the contribution of FPF-linked genes to RA-ILD susceptibility.
Copyright ©ERS 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28495692     DOI: 10.1183/13993003.02314-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  44 in total

1.  Significance of bronchiolocentric fibrosis in patients with histopathological usual interstitial pneumonia.

Authors:  Kiminobu Tanizawa; Brett Ley; Eric Vittinghoff; Brett M Elicker; Travis S Henry; Paul J Wolters; Robert Brownell; Shuo Liu; Harold R Collard; Kirk D Jones
Journal:  Histopathology       Date:  2019-04-25       Impact factor: 5.087

Review 2.  Telomeres in Interstitial Lung Disease: The Short and the Long of It.

Authors:  Andrew M Courtwright; Souheil El-Chemaly
Journal:  Ann Am Thorac Soc       Date:  2019-02

3.  Telomere length and genetic variant associations with interstitial lung disease progression and survival.

Authors:  Chad A Newton; Justin M Oldham; Brett Ley; Vikram Anand; Ayodeji Adegunsoye; Gabrielle Liu; Kiran Batra; Jose Torrealba; Julia Kozlitina; Craig Glazer; Mary E Strek; Paul J Wolters; Imre Noth; Christine Kim Garcia
Journal:  Eur Respir J       Date:  2019-04-11       Impact factor: 16.671

Review 4.  Familial Interstitial Lung Disease.

Authors:  Jonathan A Kropski
Journal:  Semin Respir Crit Care Med       Date:  2020-04-12       Impact factor: 3.119

Review 5.  Insights from human genetic studies of lung and organ fibrosis.

Authors:  Christine Kim Garcia
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

6.  Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations.

Authors:  Simone Feurstein; Ayodeji Adegunsoye; Danijela Mojsilovic; Rekha Vij; Allison H West DePersia; Padma Sheila Rajagopal; Afaf Osman; Robert H Collins; Raymond H Kim; Steven D Gore; Peter Greenberg; Lucy A Godley; Zejuan Li; Daniela Del Gaudio; Hari Prasanna Subramanian; Soma Das; Tom Walsh; Suleyman Gulsuner; Jeremy P Segal; Aliya N Husain; Sandeep Gurbuxani; Mary-Claire King; Mary E Strek; Jane E Churpek
Journal:  Blood Adv       Date:  2020-10-13

Review 7.  Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.

Authors:  Emily K Wu; Robert D Ambrosini; R Matthew Kottmann; Christopher T Ritchlin; Edward M Schwarz; Homaira Rahimi
Journal:  Curr Rheumatol Rev       Date:  2019

8.  African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis.

Authors:  Ayodeji Adegunsoye; Justin M Oldham; Shashi K Bellam; Jonathan H Chung; Paul A Chung; Kathleen M Biblowitz; Steven Montner; Cathryn Lee; Scully Hsu; Aliya N Husain; Rekha Vij; Gokhan Mutlu; Imre Noth; Matthew M Churpek; Mary E Strek
Journal:  Eur Respir J       Date:  2018-06-14       Impact factor: 16.671

9.  MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

Authors:  Pierre-Antoine Juge; Joyce S Lee; Esther Ebstein; Hiroshi Furukawa; Evgenia Dobrinskikh; Steven Gazal; Caroline Kannengiesser; Sébastien Ottaviani; Shomi Oka; Shigeto Tohma; Naoyuki Tsuchiya; Jorge Rojas-Serrano; Montserrat I González-Pérez; Mayra Mejía; Ivette Buendía-Roldán; Ramcés Falfán-Valencia; Enrique Ambrocio-Ortiz; Effrosyni Manali; Spyros A Papiris; Theofanis Karageorgas; Dimitrios Boumpas; Katarina Antoniou; Coline H M van Moorsel; Joanne van der Vis; Yaël A de Man; Jan C Grutters; Yaping Wang; Raphaël Borie; Lidwine Wemeau-Stervinou; Benoît Wallaert; René-Marc Flipo; Hilario Nunes; Dominique Valeyre; Nathalie Saidenberg-Kermanac'h; Marie-Christophe Boissier; Sylvain Marchand-Adam; Aline Frazier; Pascal Richette; Yannick Allanore; Jean Sibilia; Claire Dromer; Christophe Richez; Thierry Schaeverbeke; Huguette Lioté; Gabriel Thabut; Nadia Nathan; Serge Amselem; Martin Soubrier; Vincent Cottin; Annick Clément; Kevin Deane; Avram D Walts; Tasha Fingerlin; Aryeh Fischer; Jay H Ryu; Eric L Matteson; Timothy B Niewold; Deborah Assayag; Andrew Gross; Paul Wolters; Marvin I Schwarz; Michael Holers; Joshua J Solomon; Tracy Doyle; Ivan O Rosas; Cornelis Blauwendraat; Mike A Nalls; Marie-Pierre Debray; Catherine Boileau; Bruno Crestani; David A Schwartz; Philippe Dieudé
Journal:  N Engl J Med       Date:  2018-10-20       Impact factor: 91.245

Review 10.  Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.

Authors:  Yujie Dai; Weina Wang; Yikai Yu; Shaoxian Hu
Journal:  Clin Rheumatol       Date:  2020-08-13       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.